{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:58:21Z","timestamp":1768589901398,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by the destruction of interlobular biliary ductules, which progressively leads to cholestasis, hepatic fibrosis, cirrhosis, and eventually liver failure. Several mouse models have been used to clarify the pathogenesis of PBC and are generally considered reflective of an autoimmune cholangitis. Most models focus on issues of molecular mimicry between the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2), the major mitochondrial autoantigen of PBC and xenobiotic cross reactive chemicals. None have focused on the classic models of breaking tolerance, namely immunization with self-tissue. Here, we report a novel mouse model of autoimmune cholangitis via immunization with syngeneic bile duct protein (BDP). Our results demonstrate that syngeneic bile duct antigens efficiently break immune tolerance of recipient mice, capturing several key features of PBC, including liver-specific inflammation focused on portal tract areas, increased number and activation state of CD4 and CD8 T cells in the liver and spleen. Furthermore, the germinal center (GC) responses in the spleen were more enhanced in our mouse model. Finally, these mice were 100% positive for anti-mitochondrial antibodies (AMAs). In conclusion, we developed a novel mouse model of PBC that may help to elucidate the detailed mechanism of this complex disease.<\/jats:p>","DOI":"10.1038\/s41598-017-15661-6","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T09:58:58Z","timestamp":1509962338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization"],"prefix":"10.1038","volume":"7","author":[{"given":"Wen-Tao","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Di","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"15661_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan, M. M. & Gershwin, M. E. Primary biliary cirrhosis. N Engl J Med. \n                           353, 1261\u20131273 (2005).","journal-title":"N Engl J Med."},{"key":"15661_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor, K. D. et al. Primary biliary cirrhosis. Hepatology. \n                           50, 291\u2013308 (2009).","journal-title":"Hepatology."},{"key":"15661_CR3","doi-asserted-by":"publisher","first-page":"610504","DOI":"10.1155\/2012\/610504","volume":"2012","author":"DS Smyk","year":"2012","unstructured":"Smyk, D. S. et al. Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol. \n                           2012, 610504 (2012).","journal-title":"Clin Dev Immunol."},{"key":"15661_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00795-006-0321-z","volume":"39","author":"K Harada","year":"2006","unstructured":"Harada, K. & Nakanuma, Y. Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol. \n                           39, 55\u201361 (2006).","journal-title":"Med Mol Morphol."},{"key":"15661_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","volume":"66","author":"GJ Webb","year":"2016","unstructured":"Webb, G. J. & Hirschfield, G. M. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. \n                           66, 25\u201339 (2016).","journal-title":"J Autoimmun."},{"key":"15661_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaut.2016.06.020","volume":"74","author":"H Long","year":"2016","unstructured":"Long, H., Yin, H., Wang, L., Gershwin, M. E. & Lu, Q. J. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun. \n                           74, 118\u2013138 (2016).","journal-title":"J Autoimmun."},{"key":"15661_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.clinre.2016.05.011","volume":"40","author":"S Marzorati","year":"2016","unstructured":"Marzorati, S., Lieo, A., Carbone, M., Gershwin, M. E. & Invernizzi, P. The epigenetics of PBC: The link between genetic susceptibility and environment. Clin Res Hepatol Gas. \n                           40, 650\u2013659 (2016).","journal-title":"Clin Res Hepatol Gas."},{"key":"15661_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/hep.26157","volume":"57","author":"RCY Chen","year":"2013","unstructured":"Chen, R. C. Y. et al. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology. \n                           57, 1498\u20131508 (2013).","journal-title":"Hepatology."},{"key":"15661_CR9","doi-asserted-by":"publisher","first-page":"26992","DOI":"10.18632\/oncotarget.8853","volume":"7","author":"YQ Yang","year":"2016","unstructured":"Yang, Y. Q. et al. Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis. Oncotarget. \n                           7, 26992\u201327006 (2016).","journal-title":"Oncotarget."},{"key":"15661_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","volume":"75","author":"S Hisamoto","year":"2016","unstructured":"Hisamoto, S. et al. Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis. J Autoimmun. \n                           75, 150\u2013160 (2016).","journal-title":"J Autoimmun."},{"key":"15661_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hep.21522","volume":"45","author":"Y Moritoki","year":"2007","unstructured":"Moritoki, Y. et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology. \n                           45, 314\u2013322 (2007).","journal-title":"Hepatology."},{"key":"15661_CR12","doi-asserted-by":"crossref","unstructured":"Tang, R. et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut (2017).","DOI":"10.1136\/gutjnl-2016-313332"},{"key":"15661_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1586\/14737159.2016.1164038","volume":"16","author":"PS Leung","year":"2016","unstructured":"Leung, P. S. et al. A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis. Expert Rev Mol Diagn. \n                           16, 697\u2013705 (2016).","journal-title":"Expert Rev Mol Diagn."},{"key":"15661_CR14","doi-asserted-by":"crossref","unstructured":"Shuai, Z. et al. The Fingerprint of Antimitochondrial Antibodies and the Etiology of Primary Biliary Cholangitis. Hepatology (2017).","DOI":"10.1002\/hep.29059"},{"key":"15661_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/(SICI)1098-2825(1998)12:2<77::AID-JCLA1>3.0.CO;2-G","volume":"12","author":"M Yamashiki","year":"1998","unstructured":"Yamashiki, M. et al. Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults. J Clin Lab Anal. \n                           12, 77\u201382 (1998).","journal-title":"J Clin Lab Anal."},{"key":"15661_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","volume":"64","author":"GJ Webb","year":"2015","unstructured":"Webb, G. J., Siminovitch, K. A. & Hirschfield, G. M. The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun. \n                           64, 42\u201352 (2015).","journal-title":"J Autoimmun."},{"key":"15661_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","volume":"177","author":"S Oertelt","year":"2006","unstructured":"Oertelt, S. et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol. \n                           177, 1655\u20131660 (2006).","journal-title":"J Immunol."},{"key":"15661_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12016-015-8482-y","volume":"48","author":"T Katsumi","year":"2015","unstructured":"Katsumi, T. et al. Animal models of primary biliary cirrhosis. Clin Rev Allergy Immunol. \n                           48, 142\u2013153 (2015).","journal-title":"Clin Rev Allergy Immunol."},{"key":"15661_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","volume":"12","author":"L Gorelik","year":"2000","unstructured":"Gorelik, L. & Flavell, R. A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. \n                           12, 171\u2013181 (2000).","journal-title":"Immunity."},{"key":"15661_CR20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/hep.21385","volume":"44","author":"K Wakabayashi","year":"2006","unstructured":"Wakabayashi, K. et al. IL-2 receptor alpha(\u2212\/\u2212) mice and the development of primary biliary cirrhosis. Hepatology. \n                           44, 1240\u20131249 (2006).","journal-title":"Hepatology."},{"key":"15661_CR21","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.4049\/jimmunol.175.3.1965","volume":"175","author":"R Sharma","year":"2005","unstructured":"Sharma, R., Bagavant, H., Jarjour, W. N., Sung, S. S. & Ju, S. T. The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis. J Immunol. \n                           175, 1965\u20131973 (2005).","journal-title":"J Immunol."},{"key":"15661_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi, K. et al. Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology. \n                           48, 531\u2013540 (2008).","journal-title":"Hepatology."},{"key":"15661_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.chom.2008.03.009","volume":"3","author":"J Mattner","year":"2008","unstructured":"Mattner, J. et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. \n                           3, 304\u2013315 (2008).","journal-title":"Cell Host Microbe."},{"key":"15661_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/cei.12224","volume":"175","author":"JJ Wang","year":"2014","unstructured":"Wang, J. J. et al. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10\/Idd18) mice. Clin Exp Immunol. \n                           175, 192\u2013201 (2014).","journal-title":"Clin Exp Immunol."},{"key":"15661_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","volume":"51","author":"Y Yao","year":"2014","unstructured":"Yao, Y. et al. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(\u2212\/\u2212) mice. J Autoimmun. \n                           51, 99\u2013108 (2014).","journal-title":"J Autoimmun."},{"key":"15661_CR26","first-page":"4076","volume":"7","author":"SJ Lee","year":"2014","unstructured":"Lee, S. J. et al. Immunohistochemical study for the origin of ductular reaction in chronic liver disease. Int J Clin Exp Pathol. \n                           7, 4076\u20134085 (2014).","journal-title":"Int J Clin Exp Pathol."},{"key":"15661_CR27","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2007.08.020","volume":"133","author":"N Minagawa","year":"2007","unstructured":"Minagawa, N. et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology. \n                           133, 1592\u20131602 (2007).","journal-title":"Gastroenterology."},{"key":"15661_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","volume":"157","author":"K Harada","year":"2009","unstructured":"Harada, K. et al. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol. \n                           157, 261\u2013270 (2009).","journal-title":"Clin Exp Immunol."},{"key":"15661_CR29","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1073\/pnas.0802702105","volume":"105","author":"K Takeda","year":"2008","unstructured":"Takeda, K. et al. Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci USA \n                           105, 10895\u201310900 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"15661_CR30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22736","volume":"49","author":"A Lleo","year":"2009","unstructured":"Lleo, A. et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. \n                           49, 871\u2013879 (2009).","journal-title":"Hepatology."},{"key":"15661_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.23783","volume":"52","author":"A Lleo","year":"2010","unstructured":"Lleo, A. et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology. \n                           52, 987\u2013998 (2010).","journal-title":"Hepatology."},{"key":"15661_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/clim.1999.4690","volume":"91","author":"A Parikh-Patel","year":"1999","unstructured":"Parikh-Patel, A., Gold, E., Mackay, I. R. & Gershwin, M. E. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol. \n                           91, 206\u2013218 (1999).","journal-title":"Clin Immunol."},{"key":"15661_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/hep.21076","volume":"43","author":"A Ala","year":"2006","unstructured":"Ala, A. et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. \n                           43, 525\u2013531 (2006).","journal-title":"Hepatology."},{"key":"15661_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra, K., Beuers, U. & Ponsioen, C. Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. \n                           56, 1181\u20131188 (2012).","journal-title":"J Hepatol."},{"key":"15661_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/jaut.1999.0299","volume":"13","author":"K Tsuji","year":"1999","unstructured":"Tsuji, K. et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun. \n                           13, 171\u2013178 (1999).","journal-title":"J Autoimmun."},{"key":"15661_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","volume":"30","author":"DE Jones","year":"1999","unstructured":"Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F. & James, O. F. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol. \n                           30, 402\u2013407 (1999).","journal-title":"J Hepatol."},{"key":"15661_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi, C. et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. \n                           127, 485\u2013492 (2004).","journal-title":"Gastroenterology."},{"key":"15661_CR38","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.4049\/jimmunol.173.4.2315","volume":"173","author":"S Koarada","year":"2004","unstructured":"Koarada, S. et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol. \n                           173, 2315\u20132323 (2004).","journal-title":"J Immunol."},{"key":"15661_CR39","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas, J. T. et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology. \n                           134, 1482\u20131493 (2008).","journal-title":"Gastroenterology."},{"key":"15661_CR40","first-page":"120","volume":"78","author":"Y Hayashi","year":"1989","unstructured":"Hayashi, Y., Utsuyama, M., Kurashima, C. & Hirokawa, K. Spontaneous development of organ-specific autoimmune lesions in aged C57BL\/6 mice. Clinical and experimental immunology. \n                           78, 120\u2013126 (1989).","journal-title":"Clinical and experimental immunology."},{"key":"15661_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1440-1746.1993.tb01168.x","volume":"8","author":"K Kanda","year":"1993","unstructured":"Kanda, K., Onji, M. & Ohta, Y. Spontaneous occurrence of autoimmune cholangitis in senescent mice. Journal of gastroenterology and hepatology. \n                           8, 7\u201314 (1993).","journal-title":"Journal of gastroenterology and hepatology."},{"key":"15661_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/gut.15.6.473","volume":"15","author":"AN Hamlyn","year":"1974","unstructured":"Hamlyn, A. N. & Sherlock, S. The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales. Gut. \n                           15, 473\u2013479 (1974).","journal-title":"Gut."},{"key":"15661_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2188\/jea.15.24","volume":"15","author":"F Sakauchi","year":"2005","unstructured":"Sakauchi, F., Mori, M., Zeniya, M. & Toda, G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. Journal of epidemiology. \n                           15, 24\u201328 (2005).","journal-title":"Journal of epidemiology."},{"key":"15661_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2014.00266","volume":"5","author":"PS Sung","year":"2014","unstructured":"Sung, P. S., Racanelli, V. & Shin, E. C. CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection. Front Immunol. \n                           5, 266 (2014).","journal-title":"Front Immunol."},{"key":"15661_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2013.14","volume":"2","author":"J Schmidt","year":"2013","unstructured":"Schmidt, J., Blum, H. E. & Thimme, R. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerg Microbes Infect. \n                           2, e15 (2013).","journal-title":"Emerg Microbes Infect."},{"key":"15661_CR46","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1056\/NEJMc052618","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan, M. M. & Gershwin, M. E. Primary biliary cirrhosis - Reply. New Engl J Med. \n                           353, 2720\u20132720 (2005).","journal-title":"New Engl J Med."},{"key":"15661_CR47","first-page":"G1054","volume":"296","author":"S Kuboki","year":"2009","unstructured":"Kuboki, S. et al. Distinct contributions of CD4(+) T cell subsets in hepatic ischemia\/reperfusion injury. Am J Physiol-Gastr L. \n                           296, G1054\u2013G1059 (2009).","journal-title":"Am J Physiol-Gastr L."},{"key":"15661_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau, M. et al. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17\/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver. J Immunol. \n                           196, 97\u2013105 (2016).","journal-title":"J Immunol."},{"key":"15661_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.18632\/oncotarget.1179","volume":"4","author":"G Willimsky","year":"2013","unstructured":"Willimsky, G., Protzer, U., Knolle, P. & Heikenwalder, M. Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key? Oncotarget. \n                           4, 1117\u20131118 (2013).","journal-title":"Oncotarget."},{"key":"15661_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2015.10.005","volume":"66","author":"YH Hsueh","year":"2016","unstructured":"Hsueh, Y. H., Chang, Y. N., Loh, C. E., Gershwin, M. E. & Chuang, Y. H. AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis. J Autoimmun. \n                           66, 89\u201397 (2016).","journal-title":"J Autoimmun."},{"key":"15661_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/hep.25969","volume":"57","author":"Y Popov","year":"2013","unstructured":"Popov, Y. Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet? Hepatology. \n                           57, 429\u2013431 (2013).","journal-title":"Hepatology."},{"key":"15661_CR52","doi-asserted-by":"crossref","unstructured":"Ma, H. D. et al. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation. J Autoimmun (2017).","DOI":"10.1016\/j.jaut.2016.12.012"},{"key":"15661_CR53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi, S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. \n                           6, 345\u2013352 (2005).","journal-title":"Nat Immunol."},{"key":"15661_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. \n                           30, 531\u2013564 (2012).","journal-title":"Annu Rev Immunol."},{"key":"15661_CR55","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nri3464","volume":"13","author":"S Sakaguchi","year":"2013","unstructured":"Sakaguchi, S., Vignali, D. A., Rudensky, A. Y., Niec, R. E. & Waldmann, H. The plasticity and stability of regulatory T cells. Nat Rev Immunol. \n                           13, 461\u2013467 (2013).","journal-title":"Nat Rev Immunol."},{"key":"15661_CR56","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.4049\/jimmunol.181.10.7221","volume":"181","author":"HX Wei","year":"2008","unstructured":"Wei, H. X. et al. CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice. J Immunol. \n                           181, 7221\u20137229 (2008).","journal-title":"J Immunol."},{"key":"15661_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jhep.2013.05.034","volume":"59","author":"YH Oo","year":"2013","unstructured":"Oo, Y. H. & Sakaguchi, S. Regulatory T-cell directed therapies in liver diseases. J Hepatol. \n                           59, 1127\u20131134 (2013).","journal-title":"J Hepatol."},{"key":"15661_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaut.2015.09.002","volume":"66","author":"JB Yang","year":"2016","unstructured":"Yang, J. B. et al. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy. J Autoimmun. \n                           66, 108\u2013117 (2016).","journal-title":"J Autoimmun."},{"key":"15661_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","volume":"59","author":"YH Wang","year":"2015","unstructured":"Wang, Y. H. et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun. \n                           59, 26\u201337 (2015).","journal-title":"J Autoimmun."},{"key":"15661_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","volume":"27","author":"CA Aoki","year":"2006","unstructured":"Aoki, C. A. et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun. \n                           27, 50\u201353 (2006).","journal-title":"J Autoimmun."},{"key":"15661_CR61","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.21123","volume":"43","author":"RY Lan","year":"2006","unstructured":"Lan, R. Y. et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology. \n                           43, 729\u2013737 (2006).","journal-title":"Hepatology."},{"key":"15661_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","volume":"156","author":"G Rong","year":"2009","unstructured":"Rong, G. et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol. \n                           156, 217\u2013225 (2009).","journal-title":"Clin Exp Immunol."},{"key":"15661_CR63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu Rev Immunol. \n                           30, 429\u2013457 (2012).","journal-title":"Annu Rev Immunol."},{"key":"15661_CR64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.25032","volume":"62","author":"N Simpson","year":"2010","unstructured":"Simpson, N. et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. \n                           62, 234\u2013244 (2010).","journal-title":"Arthritis Rheum."},{"key":"15661_CR65","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2012.04.133","volume":"422","author":"XY Li","year":"2012","unstructured":"Li, X. Y. et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren\u2019s syndrome. Biochem Biophys Res Commun. \n                           422, 238\u2013244 (2012).","journal-title":"Biochem Biophys Res Commun."},{"key":"15661_CR66","first-page":"827480","volume":"2012","author":"J Ma","year":"2012","unstructured":"Ma, J. et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol. \n                           2012, 827480 (2012).","journal-title":"Clin Dev Immunol."},{"key":"15661_CR67","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1186\/ar4100","volume":"14","author":"R Liu","year":"2012","unstructured":"Liu, R. et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther. \n                           14, R255 (2012).","journal-title":"Arthritis Res Ther."},{"key":"15661_CR68","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1210\/jc.2011-2003","volume":"97","author":"C Zhu","year":"2012","unstructured":"Zhu, C. et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. \n                           97, 943\u2013950 (2012).","journal-title":"J Clin Endocrinol Metab."},{"key":"15661_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.27306","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology. \n                           61, 627\u2013638 (2015).","journal-title":"Hepatology."},{"key":"15661_CR70","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hep.27552","volume":"61","author":"GJ Webb","year":"2015","unstructured":"Webb, G. J. & Hirschfield, G. M. Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosis. Hepatology. \n                           61, 424\u2013427 (2015).","journal-title":"Hepatology."},{"key":"15661_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo, A. et al. Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci Rep. \n                           6, 25906 (2016).","journal-title":"Sci Rep."},{"key":"15661_CR72","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.27313","volume":"60","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology. \n                           60, 1708\u20131716 (2014).","journal-title":"Hepatology."},{"key":"15661_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2013.07.008","volume":"46","author":"YR Deng","year":"2013","unstructured":"Deng, Y. R. et al. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. J Autoimmun. \n                           46, 25\u201334 (2013).","journal-title":"J Autoimmun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15661-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:22:44Z","timestamp":1671801764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15661-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15661"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15661-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]},"assertion":[{"value":"23 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15246"}}